Director Trades: Who’s in the money and who’s buying up large?
Link copied to
Here’s our weekly look at which ASX small cap directors are buying or selling their own stock (week of Oct 1):
There were only about 11 small cap director trades last week but two cracked the million-dollar mark.
The biggest deal was Capitol Health (ASX:CAJ) managing director Andrew Harrison’s sale of $1.8 million worth of stock.
Mr Harrison had converted 10 million options and to pay for it, then sold off 6.5 million. He is still up 3.5m shares and owns less than 1 per cent of the company.
Capitol Health unsuccessfully tried to buy larger rival Integral Diagnostics this year.
>> Scroll down for a table of major ASX small cap director trades reported last week
The other million dollar deal was Pierre Goosen’s buy-in to an Urbanise (ASX:UBN) capital raising.
Technically he didn’t actually spend the money — his UK-based financial services firm Argosy underwrote an entitlement offer. The $4 million offer saw a 56 per cent shortfall.
Mr Goosen lives in the Isle of Man and his company bought into Urbanise in January last year, and now owns 43 per cent of the company.
Homeloans (ASX:HOM) directors Michael Jefferies and Robert Scoot swapped $620,000 worth of stock, with the latter selling 1m share to the former.
Melbourne banker David Williams was active again, spending a total of $308,000 on real estate rating site RMA Global (ASX:RMY) and medical products seller Medical Developments International (ASX:MVP)
It comes a week after it bought $84,000 worth of PolyNovo (ASX:PNV) shares.
Mr Williams now owns 30 per cent of RMA, 15 per cent of Medical, and just 2.5 per cent of PolyNovo.
Paul Atherley has made his first purchase of Pensana Metals (ASX:PM8) since joining the board in May. Usually his name pops up in relation to Berkeley Energia (ASX: BKY) where he is the chief and managing director.
Until last month Pensana was Rift Valley Resources.
Mr Artherley spent $150,000 on 10m shares as part of a recent capital raising, and that buy-in has just been approved by shareholders.
And the former Nufarm boss and wine maker has made a $107,000 purchase of Leaf Resources (ASX:LER) shares.
He bought $100,000 via a capital raising in the company he chairs.
Four directors received nig piles of stock last week in lieu of fees and as performance rights have vested.
Performance rights are an incentive given to managers and executives if the company meets set performance criteria are met, such as earnings per share targets.
The biggest winners were Base Resources’ (ASX:BSE) Colin Bwye and managing director Tim Carstons, who were the happy recipients of $2m worth of stock.
The rights were part of a long term incentive plan set up in 2015.
Immutep’s (ASX:IMM) Pete Meyers and Grant Chamberlain made the equivalent of $134,000 and and $232,000 respectively from exercising performance rights, after taking all of their fees in rights.
Screening and shade products maker Gale Pacific’s (ASX:GAP) managing director Nicholas Pritchard had 913,000 performance rights vest, worth $324,000.
Here’s a table of major ASX small cap director trades reported last week:
Swipe or scroll for full table. Click headings to sort
|ASX code||Company||Director||Change||Date||Volume||$||Where||Total holdings controlled|
|CAJ||Capitol Health||Andrew Harrison||Sell||Sept 24-28||6.5m||1788095||On market||7m|
|JLG||Johns Lyng Group||Scottt Didier||Buy||Sept 25||150,000||131974||On market||58m|
|PM8||Pensana Metals||Paul Atherley||Buy||Sept 25||10m||150000||Placement||10m|
|RMY||RMA Global||David Williams||Buy||Sept 27 and Oct 1||500,000||118645||On market||109.2m|
|IMM||Immutep||Pete Meyers||Buy||Oct 2||2.7m||0||Convert performance rights||5.5m|
|IMM||Immutep||Grant Chamberlain||Buy||Oct 2||4.7m||0||Convert performance rights||4.7m|
|HOM||Homeloans||Michael Jefferies||Buy||Oct 1||1m||620000||Off market||1.7m|
|HOM||Homeloans||Robert Scott||Sell||Oct 1||1m||620000||Off market||12.1m|
|LER||Leaf Resources||Douglas Rathbone||Buy||May 7||1.4m||107000||Placement and on market||2.8m|
|BSE||Base Resources||Tim Carstons||Buy||Oct 4||7m||0||Convert performance rights||9.6m|
|BSE||Base Resources||Colin Bwye||Buy||Oct 4||7m||0||Convert performance rights||10.1m|
|GAP||Gale Pacific||Nicholas Pritchard||Buy||Oct 1||913,000||0||Vesting performance rights||1.4m|
|LPD||Lepidico||Gary Johnson||Buy||Oct 1||8.7m||165192||Entitlement offer||362m|
|UBN||Urbanise.com||Pierre Goosen||Buy||Oct 3||51.2m||1381451||Entitlement offer||230m|
|SVH||Silver Heritage Group||Matthew Hunter||Buy||Oct 1||5.6m||111640||Entitlement offer||20.9m|
|MVP||Medical Developments International||David Williams||Buy||Oct 5||50,406||189198||Dividend reinvestment plan||9.5m|
|SRS||Spicers||Gabriel Berger||Sell||Oct 1-5||4.5m||234315||On and off market||73.4m|